A detailed history of Glenmede Investment Management, LP transactions in Baxter International Inc stock. As of the latest transaction made, Glenmede Investment Management, LP holds 12,872 shares of BAX stock, worth $237,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,872
Previous 13,555 5.04%
Holding current value
$237,745
Previous $410 Million 99.93%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$21.71 - $31.23 $14,827 - $21,330
-683 Reduced 5.04%
12,872 $293,000
Q2 2025

Aug 14, 2025

BUY
$27.8 - $34.02 $376,829 - $461,141
13,555 New
13,555 $410 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $9.31B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Glenmede Investment Management, LP Portfolio

Follow Glenmede Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Investment Management, LP with notifications on news.